Abstract

HtrA2(Omi) protease controls protein quality in mitochondria and plays a major role in apoptosis. Its HtrA2S306A mutant (with the catalytic serine routinely disabled for an X-ray study to avoid self-degradation) is a homotrimer whose subunits contain the serine protease domain (PD) and the regulatory PDZ domain. In the inactive state, a tight interdomain interface limits penetration of both PDZ-activating ligands and PD substrates into their respective target sites. We successfully crystalized HtrA2V226K/S306A, whose active counterpart HtrA2V226K has had higher proteolytic activity, suggesting higher propensity to opening the PD-PDZ interface than that of the wild type HtrA2. Yet, the crystal structure revealed the HtrA2V226K/S306A architecture typical of the inactive protein. To get a consistent interpretation of crystallographic data in the light of kinetic results, we employed molecular dynamics (MD). V325D inactivating mutant was used as a reference. Our simulations demonstrated that upon binding of a specific peptide ligand NH2-GWTMFWV-COOH, the PDZ domains open more dynamically in the wild type protease compared to the V226K mutant, whereas the movement is not observed in the V325D mutant. The movement relies on a PDZ vs. PD rotation which opens the PD-PDZ interface in a lid-like (budding flower-like in trimer) fashion. The noncovalent hinges A and B are provided by two clusters of interfacing residues, harboring V325D and V226K in the C- and N-terminal PD barrels, respectively. The opening of the subunit interfaces progresses in a sequential manner during the 50 ns MD simulation. In the systems without the ligand only minor PDZ shifts relative to PD are observed, but the interface does not open. Further activation-associated events, e.g. PDZ-L3 positional swap seen in any active HtrA protein (vs. HtrA2), were not observed. In summary, this study provides hints on the mechanism of activation of wtHtrA2, the dynamics of the inactive HtrA2V325D, but does not allow to explain an increased activity of HtrA2V226K.

Highlights

  • The human HtrA2 protease controls protein quality in mitochondria [1, 2]

  • Expanding our former structure-activity mutation study [36], we have found that any mutations weakening inter-domain interactions at the protease domain (PD)-PDZ-PDÃ interfaces increase HtrA2 proteolytic activity, see e.g. Figs 3 and 4 and Table 2 in Ref. [38], including the V226K mutation, see above

  • The crystal structures of HtrA2S306A [31] and HtrA2S306A/V226K resolve to homotrimers having essentially identical architectures, characterized by a unique PD-PDZ arrangements not seen in the structures of other procaryotic and eukaryotic proteins of HtrA family

Read more

Summary

Introduction

The human HtrA2 (high-temperature requirement A2) protease controls protein quality in mitochondria [1, 2] It is involved in cell death (apoptosis, both caspase dependent and independent [3,4,5]) and plays a role in oncogenesis [5, 6]), and in Parkinson [4, 7, 8] and Alzheimer diseases [9,10,11,12,13]. The lobes are delimited by the N- and C-terminal αhelices, arranged parallel in space, in a C2-pseudosymmetrical manner These secondary-structure elements are connected by loops, several of which are important for proteolytic activity [15]. The active site and the catalytic triad (His, Asp, Ser) are embedded in the interface of the β-barrels

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call